NEW YORK, NY / ACCESSWIRE / June 20, 2018 / U.S. equities slumped on Tuesday as global trade concerns grew after President Trump threatened to impose an additional $400 billion in tariffs on goods from China. The Dow Jones Industrial Average plunged 1.15 percent to close at 24,700.21, while the S&P 500 Index declined 0.40 percent to close at 2,762.59. The Nasdaq Composite Index dropped 0.28 percent to close at 7,725.58.
''This is bad ... real bad, unless this is gamesmanship as in the so called 'Art of the Deal.' Either way, U.S. companies are more protected from market fallout from trade barriers than other developed countries, which has allowed the U.S. to take charge on these tariffs,'' said Voya Investment Management strategists Doug Coté and Karyn Cavanaugh.
RDI Initiates Coverage on:
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals' stock jumped 3.63% Tuesday, to close the day at $327.07. The stock recorded a trading volume of 1,075,628 shares, which was above its three months average volume of 859,060 shares. In the last year, Regeneron Pharmaceuticals' shares have traded in a range of 281.89 - 543.55. The share price has gained 16.03% from its 52 week low. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $302.12 is below its 200-day moving average of $337.15. Shares of the company are trading at a Price to Earnings ratio of 26.54. Shares of Regeneron Pharmaceuticals have gained roughly 8.37 percent in the past month and are down 13 percent year-to-date.
Access RDI's Regeneron Pharmaceuticals, Inc. Research Report at:
On Tuesday, shares of Intrexon recorded a trading volume of 1,219,990 shares, which was above the three months average volume of 1,174,153 shares. The stock ended the day 3.22% higher at $16.99. The share price has fallen 34.35% from its 52 week high with a 52 week trading range of 10.26 - 25.88. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $16.76 is above its 200-day moving average of $15.20. Shares of Intrexon have gained roughly 7.60 percent in the past month and are up 47.48 percent year-to-date.
Access RDI's Intrexon Corporation Research Report at:
Research Driven Investing
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.
For any questions, inquiries, or comments reach out to us directly at:
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.